Written Question·Department of Health and Social Care·UIN 59606
Pancreatic Cancer: Orphan Drugs
Tabled: 12 June 2025
Answered: 20 June 2025
Question
Sarah Gibson
Liberal Democrat — Chippenham
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of the Orphan Drug Regulations in stimulating innovation in treatments for pancreatic cancer.
Answer
Karin SmythThe Human Medicines Regulations include specific incentives to support orphan medicines, designed to encourage the development of medicines for rare diseases. The regulations enable the Medicines and Healthcare products Regulatory Agency (MHRA) to grant o...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 59606) →